The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10. It reported earnings in this window, a natural checkpoint for the thesis.
Mizuho Financial Group, Inc. MFG
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · Mizuho Financial Group, Inc., together with its subsidiaries, engages in banking, trust banking, securities, and other businesses related to financial services in Japan, the Americas, Europe, Asia/Oceania, and internationally.
read at $10.63
Mizuho Financial Group, Inc. holds its Markup at $10.63.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 265 days |
| Price | $10.63 |
| Valuation | 17.15 trailing · 7.65 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.38 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades at roughly a 13% discount to our $12.06 fair value, weak competitive moat, 44.90% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
| Revenue growth | 44.90% |
| Profit margin | 28.38% |
| Analyst consensus | Buy · 2 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Financial sector: banks Fail
- Debt load Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling — it does not run on borrowed money. Pass
- Interest-bearing cash Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
- Receivables Money owed to the company is 0.0% of assets, under the 49% limit. Pass
- Revenue purity Only 0.0% of revenue comes from non-compliant sources — under the 5% line. Pass
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Ethics Screen Blocks This Japanese Lender
Picture a Tokyo salaryman shifting his monthly pay through the big domestic banks. Mizuho sits right in the middle of those flows yet still fails our ethical screen on core business activity, so we pass.
The forward multiple sits at just 7.1 times and revenue growth looks strong at 45 percent, yet the moat is weak and return on equity only reaches 11 percent. For a regional bank the low multiple is no bargain. It often signals peak earnings that can fall quickly when rates or the economy turn.
Analysts see only modest upside to a 10 dollar median target and the 22 percent margin of safety to our fair value does not offset the ethical fail. Analysis, not advice.
| Forward P/E | 7.6x cheap for a company growing this fast |
| Trailing P/E | 17.1x reasonably valued |
| Revenue growth | 44.9% growing very fast |
| Profit margin | 28.4% healthy profit margins |
| Return on equity | 11.4% a modest return on shareholder capital |
| Beta | 0.38 barely tracks the market's swings |
| Market cap | $129.5B |
| Employees | 52,427 |
The risks · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on MFG
- › Europe Indexes Higher as Stoxx 600 Touches New Record The Wall Street Journal · 2d ago
- › European Indexes Mixed as Earnings Drive Sentiment The Wall Street Journal · 3d ago
- › Circle Stock Is Downgraded As Stablecoin Competition Heats Up CryptoProwl · 16d ago
- › Nissan Shareholders Vote Out Influential Director at Meeting Bloomberg · 23 Jun 2026
- › Mizuho Financial Group (MFG): Top Value Stocks to Buy Under $10 Insider Monkey · 19 Jun 2026
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in MFG's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
MFG trades on the NYSE (the company is based in Japan). As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 21% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 71%. Our forward projection puts the odds of a 10% gain over the next month near 34%. The street (2 analysts) rates it buy, with a mean price target of $10.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 8 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $8.81 | +6.5% | · | $1,065 | +6.5% |
| 2 months | $8.63 | +8.8% | · | $1,088 | +8.8% |
| 3 months | $7.72 | +21.6% | · | $1,216 | +21.6% |
| 6 months | $7.35 | +27.7% | · | $1,277 | +27.7% |
| 1 year | $5.49 | +71.0% | · | $1,710 | +71.0% |
| 2 years | $3.88 | +141.8% | $0.19 | $2,467 | +146.7% |
| 3 years | $2.87 | +227.1% | $0.26 | $3,361 | +236.1% |
| 5 years | $2.87 | +227.1% | $0.26 | $3,361 | +236.1% |
Historical returns from market close data. Past performance does not guarantee future results.